Christina Yau

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 29

Top Topics

Magnetic Resonance Imaging

Early Breast Cancer

Neoadjuvant Chemotherapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Communications medicine

Research square

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Lauren R Begg, Adrienne M Orriols, Markella Zannikou, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F Dunne, Sanjeev Balakrishnan, Roman Camarda, Diane Roth, Nicolette A Zielinski-Mozny, Christina Yau, Athanassios Vassilopoulos, Tzu-Hsuan Huang, Kwang-Youn A Kim, Dai Horiuchi
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models. Communications medicine 4 (1) (2024)
Lauren R Begg, Adrienne M Orriols, Markella Zannikou, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F Dunne, Sanjeev Balakrishnan, Roman Camarda, Diane Roth, Nicolette A Zielinski-Mozny, Christina Yau, Athanassios Vassilopoulos, Tzu-Hsuan Huang, Kwang-Youn A Kim, Dai Horiuchi
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models. Communications medicine 4 (1) (2024)
Lauren R Begg, Adrienne M Orriols, Markella Zannikou, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F Dunne, Sanjeev Balakrishnan, Roman Camarda, Diane Roth, Nicolette A Zielinski-Mozny, Christina Yau, Athanassios Vassilopoulos, Tzu-Hsuan Huang, Kwang-Youn A Kim, Dai Horiuchi
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models. Communications medicine 4 (1) (2024)
Thomas O'Keefe, Anne Wallace, Gillian L Hirst, Christina Yau, Laura J Esserman, Emma Iaconetti, Case Brabham, Paul Kim, Olivier Harismendy, Eliza Jeong, Joseph McGuire, Ann Griffin
Duration of Endocrine Treatment for DCIS impacts second events: Insights from a large cohort of cases at two academic medical centers. Research square (2024)
Gillian L Hirst, Thomas O'Keefe, Christina Yau, Emma Iaconetti, Eliza Jeong, Case Brabham, Paul Kim, Joseph McGuire, Ann Griffin, Anne Wallace, Laura J Esserman, Olivier Harismendy
Duration of Endocrine Treatment for DCIS impacts second events: Insights from a large cohort of cases at two academic medical centers. Research square (2024)
Lauren R Begg, Adrienne M Orriols, Markella Zannikou, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F Dunne, Sanjeev Balakrishnan, Roman Camarda, Diane Roth, Nicolette A Zielinski-Mozny, Christina Yau, Athanassios Vassilopoulos, Tzu-Hsuan Huang, Kwang-Youn A Kim, Dai Horiuchi
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models. Communications medicine 4 (1) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Thomas O'Keefe, Anne Wallace, Gillian L Hirst, Christina Yau, Laura J Esserman, Emma Iaconetti, Case Brabham, Paul Kim, Olivier Harismendy, Eliza Jeong, Joseph McGuire, Ann Griffin
Duration of Endocrine Treatment for DCIS impacts second events: Insights from a large cohort of cases at two academic medical centers. Research square (2024)
Lauren R Begg, Adrienne M Orriols, Markella Zannikou, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F Dunne, Sanjeev Balakrishnan, Roman Camarda, Diane Roth, Nicolette A Zielinski-Mozny, Christina Yau, Athanassios Vassilopoulos, Tzu-Hsuan Huang, Kwang-Youn A Kim, Dai Horiuchi
S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models. Communications medicine 4 (1) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Thomas O'Keefe, Christina Yau, Emma Iaconetti, Eliza Jeong, Case Brabham, Paul Kim, Joseph McGuire, Ann Griffin, Anne Wallace, Laura J Esserman, Olivier Harismendy, Gillian L Hirst
Duration of Endocrine Treatment for DCIS impacts second events: Insights from a large cohort of cases at two academic medical centers. Research square (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (4) (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA concentration as a biomarker of response and recurrence in HER2-negative breast cancer receiving neoadjuvant chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Mark Jesus M Magbanua, Ziad Ahmed, Rosalyn W Sayaman, Lamorna Brown Swigart, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen Li, Amy L Delson, Jane Perlmutter, Paula R Pohlmann, William Fraser Symmans, Douglas Yee, Nola M Hylton, Laura J Esserman, Angela M DeMichele, Hope S Rugo, Laura van 't Veer
Cell-free DNA Concentration as a Biomarker of Response and Recurrence in HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Yiwey Shieh, Jacquelyn Roger, Christina Yau, Denise M Wolf, Gillian L Hirst, Lamorna Brown Swigart, Scott Huntsman, Donglei Hu, Jovia L Nierenberg, Pooja Middha Kapoor, Rachel S Heise, Yushu Shi, Linda Kachuri, Qianqian Zhu, Song Yao, Christine B Ambrosone, Marilyn L Kwan, Bette J Caan, John S Witte, Lawrence H Kushi, Laura van 't Veer, Laura J Esserman, Elad Ziv
Development and testing of a polygenic risk score for breast cancer aggressiveness. NPJ precision oncology 7 (1) (2023)
Yiwey Shieh, Jacquelyn Roger, Christina Yau, Denise M Wolf, Gillian L Hirst, Lamorna Brown Swigart, Scott Huntsman, Donglei Hu, Jovia L Nierenberg, Pooja Middha Kapoor, Rachel S Heise, Yushu Shi, Linda Kachuri, Qianqian Zhu, Song Yao, Christine B Ambrosone, Marilyn L Kwan, Bette J Caan, John S Witte, Lawrence H Kushi, Laura van 't Veer, Laura J Esserman, Elad Ziv
Development and testing of a polygenic risk score for breast cancer aggressiveness. NPJ precision oncology 7 (1) (2023)
Yiwey Shieh, Jacquelyn Roger, Christina Yau, Denise M Wolf, Gillian L Hirst, Lamorna Brown Swigart, Scott Huntsman, Donglei Hu, Jovia L Nierenberg, Pooja Middha Kapoor, Rachel S Heise, Yushu Shi, Linda Kachuri, Qianqian Zhu, Song Yao, Christine B Ambrosone, Marilyn L Kwan, Bette J Caan, John S Witte, Lawrence H Kushi, Laura van 't Veer, Laura J Esserman, Elad Ziv
Development and testing of a polygenic risk score for breast cancer aggressiveness. NPJ precision oncology 7 (1) (2023)
Lauren R Begg, Adrienne M Orriols, Markella Zannikou, Chen Yeh, Pranathi Vadlamani, Deepak Kanojia, Rosemary Bolin, Sara F Dunne, Sanjeev Balakrishnan, Roman Camarda, Diane Roth, Nicolette A Zielinski-Mozny, Christina Yau, Athanassios Vassilopoulos, Tzu-Hsuan Huang, Kwang-Youn A Kim, Dai Horiuchi
S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibition. bioRxiv : the preprint server for biology (2023)
Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, Amy Jo Chien, Tufia C Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David M Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debasish Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica M Stringer-Reasor, Sarah L Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Douglas Yee, Donald A Berry, Laura J Esserman
Neoadjuvant trebananib plus paclitaxel-based chemotherapy for stage II/III breast cancer in the adaptively randomized I-SPY2 trial - Efficacy and biomarker discovery. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A Parker, A Jo Chien, Anne M Wallace, Rashmi Murthy, Kathy S Albain, Erin D Ellis, Heather Beckwith, Barbara B Haley, Anthony D Elias, Judy C Boughey, Rachel L Yung, Claudine Isaacs, Amy S Clark, Hyo S Han, Rita Nanda, Qamar J Khan, Kristen K Edmiston, Erica Stringer-Reasor, Elissa Price, Bonnie Joe, Minetta C Liu, Lamorna Brown Swigart, Emanuel F Petricoin, Julia D Wulfkuhle, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Adam L Asare, Jeffrey B Matthews, Michelle Melisko, Jane Perlmutter, Hope S Rugo, William Fraser Symmans, Laura van 't Veer, Nola M Hylton, Angela M DeMichele, Donald A Berry, Laura J Esserman
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer. NPJ breast cancer 8 (1) (2022)
Annelie Johansson, Huma Dar, Laura van 't Veer, Nicholas P Tobin, Gizeh Perez-Tenorio, Anna Nordenskjöld, Ulla Johansson, Johan Hartman, Lambert Skoog, Christina Yau, Christopher C Benz, Laura J Esserman, Olle Stål, Bo Nordenskjöld, Tommy Fornander, Linda S Lindström
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (35) (2022)
Natsuko Onishi, Wen Li, David C Newitt, Roy J Harnish, Fredrik Strand, Alex Anh-Tu Nguyen, Vignesh Amal Arasu, Jessica E Gibbs, Ella F Jones, Lisa J Wilmes, John Kornak, Bonnie N. Joe, Elissa R Price, Haydee Ojeda-Fournier, Mohammad Eghtedari, Kathryn W Zamora, Stefanie A Woodard, Heidi R Umphrey, Michael T Nelson, An Ly Church, Patrick J Bolan, Theresa Kuritza, Kathleen Ward, Kevin Morley, Dulcy Wolverton, Kelly Fountain, Dan Lopez Paniagua, Lara Hardesty, Kathleen R Brandt, Elizabeth S McDonald, Mark Rosen, Despina Kontos, Hiroyuki Abe, Deepa Sheth, Erin Crane, Charlotte Dillis, Pulin Sheth, Linda H Larsen, Dae Hee Bang, Bruce Porter, Karen Y Oh, Neda Jafarian, Luminita A Tudorica, Bethany Niell, Jennifer Drukteinis, Mary S Newell, Marina E Giurescu, Elise Berman, Constance D Lehman, Savannah C Partridge, Kimberly A Fitzpatrick, Marisa H Borders, Wei Tse Yang, Basak Erguvan Dogan, Sally Hayward Goudreau, Thomas L Chenevert, Christina Yau, Angela M DeMichele, Donald A Berry, Laura J Esserman, Nola M Hylton
Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology 301 (2) (2021)
Mark Jesus M Magbanua, Wen Li, Denise M Wolf, Christina Yau, Gillian L Hirst, Lamorna Brown Swigart, David C Newitt, Jessica Gibbs, Amy L Delson, Ekaterina Kalashnikova, Alexey Aleshin, Bernhard Zimmermann, A Jo Chien, Debasish Tripathy, Laura J Esserman, Nola M Hylton, Laura van 't Veer
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk. NPJ breast cancer 7 (1) (2021)